Sharp Edge Labs Revenue and Competitors
Estimated Revenue & Valuation
- Sharp Edge Labs's estimated annual revenue is currently $1.7M per year.
- Sharp Edge Labs's estimated revenue per employee is $155,000
Employee Data
- Sharp Edge Labs has 11 Employees.
- Sharp Edge Labs grew their employee count by 0% last year.
Sharp Edge Labs's People
Name | Title | Email/Phone |
---|
Sharp Edge Labs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Sharp Edge Labs?
Sharp Edge Labs is a preclinical-stage life sciences company developing drugs for protein trafficking disorders. Many rare/genetic diseases result from trafficking disorders, and the Sharp Edge platform allows these to be pursued at industrial screening scale for the first time. Our monogenic disease focus de-risks the clinical path. Each pipeline program has a genetically identifiable subset of patients and an early Phase IB pharmacodynamic readout. The company has programs in CF, Frontotemporal Dementia, and genetic subsets of Alzheimer’s and Parkinson’s. The team and its advisors includes ex and current Genzyme/Sanofi, Synageva, Pfizer and Shire executives.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 11 | -21% | $10.3M |
#2 | $0.9M | 11 | -8% | N/A |
#3 | $1M | 11 | 175% | N/A |
#4 | N/A | 11 | 57% | N/A |
#5 | $1.7M | 11 | -15% | N/A |